Percy H. Carter Blueprint Medicines Corp (BPMC) insider trading activity

Percy H. Carter is Chief Scientific Officer of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2025, when has been sold 56,614 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Percy H. Carter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2025	SELL Sale (or disposition) back to the issuer	-	56,614 Reduced 75.98%	17,894 Common Stock
Jul 17 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	17,894 Reduced 100.0%	0 Common Stock
Jul 17 2025	BUY Grant, award, or other acquisition	-	21,353 Added 22.27%	74,508 Common Stock
Jul 03 2025	SELL Open market or private sale	$134,790 $128.25 p/Share	1,051 Reduced 1.94%	53,155 Common Stock
Jun 03 2025	SELL Open market or private sale	$340,032 $127.88 p/Share	2,659 Reduced 4.68%	54,206 Common Stock
Mar 05 2025	SELL Open market or private sale	$313,464 $88.8 p/Share	3,530 Reduced 5.84%	56,865 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	11,000 Added 15.41%	60,395 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	7,500 Added 13.18%	49,395 Common Stock
Jun 05 2024	SELL Open market or private sale	$420,520 $105.13 p/Share	4,000 Reduced 8.72%	41,895 Common Stock
Jun 03 2024	SELL Open market or private sale	$259,263 $106.43 p/Share	2,436 Reduced 5.04%	45,895 Common Stock
Mar 07 2024	SELL Open market or private sale	$207,317 $90.69 p/Share	2,286 Reduced 4.52%	48,331 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	12,500 Added 19.8%	50,617 Common Stock
Jun 05 2023	SELL Open market or private sale	$120,102 $52.06 p/Share	2,307 Reduced 5.71%	38,117 Common Stock
Mar 06 2023	SELL Open market or private sale	$34,435 $45.25 p/Share	761 Reduced 1.85%	40,424 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	12,500 Added 23.28%	41,185 Common Stock
Jun 06 2022	SELL Open market or private sale	$114,022 $59.76 p/Share	1,908 Reduced 6.24%	28,685 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	8,750 Added 22.24%	30,593 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	21,843 Added 50.0%	21,843 Common Stock

PHC

Percy H. Carter

Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account